The global chlamydia diagnostics market, valued at USD 1.17 billion in 2022, is on an impressive growth trajectory. According ...

In light of the recently announced plan to put 2.5 million people on injectable pre-exposure prophylaxis (PrEP), specifically lenacapavir, by 2027, AIDS Healthcare Foundation (AHF) urges global health ...